Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2023 Filed Jan 31, 2023 19:08 UTC |
Davidoff Michael J.SVP, Payer Business
|
Exercise / conversionCommon Stock | 11,378 | $8.03 | $91,365.34 |
DisclosureSEC source: 0001562180-23-000766 · primarydocument.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 21:36 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 649 | $36.07 | $23,406.96 |
DisclosureSEC source: 0001562180-23-000533 · primarydocument.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,507 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 16:57 UTC |
Davidoff Michael J.SVP, Payer Business
|
Tax withholdingCommon Stock | 2,324 | $35.00 | $81,340.00 |
DisclosureSEC source: 0001562180-23-000480 · primarydocument.xml · nonDerivative · entry 5 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,214 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:52 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 964 | $35.00 | $33,740.00 |
DisclosureSEC source: 0001562180-23-000478 · primarydocument.xml · nonDerivative · entry 5 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,867 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:59 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 1,008 | $35.00 | $35,280.00 |
DisclosureSEC source: 0001562180-23-000481 · primarydocument.xml · nonDerivative · entry 5 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,759 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:49 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 2,233 | $35.00 | $78,155.00 |
DisclosureSEC source: 0001562180-23-000476 · primarydocument.xml · nonDerivative · entry 5 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,025 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:48 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 55,346 | $35.00 | $1,937,110.00 |
DisclosureSEC source: 0001562180-23-000475 · primarydocument.xml · nonDerivative · entry 5 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215,156 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 16:51 UTC |
Rasmussen RandyChief Financial Officer
|
GrantCommon Stock | 45,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000477 · primarydocument.xml · nonDerivative · entry 3 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,359 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 16:51 UTC |
Rasmussen RandyChief Financial Officer
|
Tax withholdingCommon Stock | 1,868 | $35.41 | $66,145.88 |
DisclosureSEC source: 0001562180-23-000477 · primarydocument.xml · nonDerivative · entry 2 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,175 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 16:57 UTC |
Davidoff Michael J.SVP, Payer Business
|
GrantCommon Stock | 31,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000480 · primarydocument.xml · nonDerivative · entry 4 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,538 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 16:57 UTC |
Davidoff Michael J.SVP, Payer Business
|
Tax withholdingCommon Stock | 1,947 | $35.41 | $68,943.27 |
DisclosureSEC source: 0001562180-23-000480 · primarydocument.xml · nonDerivative · entry 3 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,768 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 16:57 UTC |
Davidoff Michael J.SVP, Payer Business
|
Tax withholdingCommon Stock | 7,160 | $35.41 | $253,535.60 |
DisclosureSEC source: 0001562180-23-000480 · primarydocument.xml · nonDerivative · entry 2 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,715 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:52 UTC |
Linetsky DavidSVP, Life Sciences
|
GrantCommon Stock | 45,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000478 · primarydocument.xml · nonDerivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,831 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:52 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 8,824 | $35.41 | $312,457.84 |
DisclosureSEC source: 0001562180-23-000478 · primarydocument.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,647 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:52 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 2,422 | $35.41 | $85,763.02 |
DisclosureSEC source: 0001562180-23-000478 · primarydocument.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,471 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:54 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
GrantCommon Stock | 31,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000479 · primarydocument.xml · nonDerivative · entry 3 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,156 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:54 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
Tax withholdingCommon Stock | 2,124 | $35.41 | $75,210.84 |
DisclosureSEC source: 0001562180-23-000479 · primarydocument.xml · nonDerivative · entry 2 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,092 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:59 UTC |
VanDuyn Amy BethSVP, Human Resources
|
GrantCommon Stock | 19,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000481 · primarydocument.xml · nonDerivative · entry 4 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,767 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:59 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 4,226 | $35.41 | $149,642.66 |
DisclosureSEC source: 0001562180-23-000481 · primarydocument.xml · nonDerivative · entry 3 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,999 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:59 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 1,126 | $35.41 | $39,871.66 |
DisclosureSEC source: 0001562180-23-000481 · primarydocument.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,225 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:49 UTC |
Roberts EvanChief Operating Officer
|
GrantCommon Stock | 45,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000476 · primarydocument.xml · nonDerivative · entry 4 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,258 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:49 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 17,007 | $35.41 | $602,217.87 |
DisclosureSEC source: 0001562180-23-000476 · primarydocument.xml · nonDerivative · entry 3 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,074 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:49 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 2,805 | $35.41 | $99,325.05 |
DisclosureSEC source: 0001562180-23-000476 · primarydocument.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699,081 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:48 UTC |
Indig ChaimDirector · Chief Executive Officer
|
GrantCommon Stock | 70,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000475 · primarydocument.xml · nonDerivative · entry 4 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,270,502 F2 · shares: The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 15, 2024. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:48 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 31,183 | $35.41 | $1,104,190.03 |
DisclosureSEC source: 0001562180-23-000475 · primarydocument.xml · nonDerivative · entry 3 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199,901 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:48 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 6,010 | $35.41 | $212,814.10 |
DisclosureSEC source: 0001562180-23-000475 · primarydocument.xml · nonDerivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,231,084 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 16:51 UTC |
Rasmussen RandyChief Financial Officer
|
Tax withholdingCommon Stock | 1,496 | $35.41 | $52,973.36 |
DisclosureSEC source: 0001562180-23-000477 · primarydocument.xml · nonDerivative · entry 1 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,043 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 16:57 UTC |
Davidoff Michael J.SVP, Payer Business
|
Tax withholdingCommon Stock | 1,239 | $35.41 | $43,872.99 |
DisclosureSEC source: 0001562180-23-000480 · primarydocument.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · SVP, Payer Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,875 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 21:52 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 1,592 | $35.41 | $56,372.72 |
DisclosureSEC source: 0001562180-23-000478 · primarydocument.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,893 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 21:54 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
Tax withholdingCommon Stock | 1,288 | $35.41 | $45,608.08 |
DisclosureSEC source: 0001562180-23-000479 · primarydocument.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,216 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 21:59 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Tax withholdingCommon Stock | 698 | $35.41 | $24,716.18 |
DisclosureSEC source: 0001562180-23-000481 · primarydocument.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,351 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 21:49 UTC |
Roberts EvanChief Operating Officer
|
Tax withholdingCommon Stock | 1,816 | $35.41 | $64,304.56 |
DisclosureSEC source: 0001562180-23-000476 · primarydocument.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 701,886 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 21:48 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,288 | $35.41 | $116,428.08 |
DisclosureSEC source: 0001562180-23-000475 · primarydocument.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,237,094 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:36 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 597 | $33.17 | $19,800.76 |
DisclosureSEC source: 0001562180-23-000238 · primarydocument.xml · nonDerivative · entry 3 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,702 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.89 to $33.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:36 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 899 | $32.37 | $29,099.46 |
DisclosureSEC source: 0001562180-23-000238 · primarydocument.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,299 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.85 to $32.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:36 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 8,504 | $31.12 | $264,652.13 |
DisclosureSEC source: 0001562180-23-000238 · primarydocument.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,198 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.73 to $31.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:12 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
GrantCommon Stock | 242 | $21.63 | $5,234.46 |
DisclosureSEC source: 0001562180-23-000110 · primarydocument.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,504 F1 · kind: Shares purchased pursuant to the Phreesia, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 31, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on July 1, 2022. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:11 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-22-008405 · primarydocument.xml · derivative · entry 3 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,387 Underlying: Common Stock · 15,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:11 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 378 | $33.73 | $12,749.64 |
DisclosureSEC source: 0001562180-22-008405 · primarydocument.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,049 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.7265 to $33.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:11 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionCommon Stock | 15,000 | $0.84 | $12,600.00 |
DisclosureSEC source: 0001562180-22-008405 · primarydocument.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2022 Filed Dec 20, 2022 21:07 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 15 | $33.97 | $509.55 |
DisclosureSEC source: 0001562180-22-008379 · primarydocument.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,583 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:07 UTC |
Linetsky DavidSVP, Life Sciences
|
Tax withholdingCommon Stock | 36 | $33.97 | $1,222.92 |
DisclosureSEC source: 0001562180-22-008379 · primarydocument.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,598 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. Read SEC document |
| December 15, 2022 Filed May 9, 2025 20:24 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 22 | $34.01 | $748.22 |
DisclosureSEC source: 0001127602-25-013853 · form4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,770 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. The transaction was not previously reported due to administrative oversight. Forms 4 filed after the transaction date overstated the total common stock holdings of the Reporting Person's spouse by 22 shares. F2 · balance_after: The total in Column 5 has been adjusted to correct (i) an overstatement of holdings by 116 shares first reflected in a Form 4 filed on September 14, 2022 and (ii) an overstatement of holdings by 236 shares first reflected in a Form 4 filed on April 12, 2023. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 21:57 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 801 | $36.00 | $28,836.00 |
DisclosureSEC source: 0001562180-22-008318 · primarydocument.xml · nonDerivative · entry 2 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,262 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:54 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 11,377 | $34.61 | $393,754.56 |
DisclosureSEC source: 0001562180-22-008317 · primarydocument.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,485 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:57 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 3,109 | $34.40 | $106,949.60 |
DisclosureSEC source: 0001562180-22-008318 · primarydocument.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,063 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 16:28 UTC |
Rasmussen RandyChief Financial Officer
|
SaleCommon Stock | 7,395 | $31.77 | $234,913.27 |
DisclosureSEC source: 0001562180-22-008242 · primarydocument.xml · nonDerivative · entry 3 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,539 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:28 UTC |
Rasmussen RandyChief Financial Officer
|
SaleCommon Stock | 1,751 | $31.40 | $54,981.93 |
DisclosureSEC source: 0001562180-22-008242 · primarydocument.xml · nonDerivative · entry 2 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,934 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.17 to $31.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:28 UTC |
Rasmussen RandyChief Financial Officer
|
SaleCommon Stock | 8,183 | $30.17 | $246,869.65 |
DisclosureSEC source: 0001562180-22-008242 · primarydocument.xml · nonDerivative · entry 1 Rasmussen Randy · CIK 0001860230 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,685 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 26,837 | $29.78 | $799,071.68 |
DisclosureSEC source: 0001562180-22-008243 · primarydocument.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,862 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.